Julie Hill
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 0.5%
- Surgery top 2%
- Molecular Biology top 10%
- Gastroenterology top 0.2%
- Co-authors
- Eric Van CutsemMichaela LehleYung‐Jue BangA. FeyereislovaFlorian LordickYoon‐Koo KangAkira SawakiJosef Rüschoff
- Topics
- HER2/EGFR in Cancer Research (8 papers)Gastric Cancer Management and Outcomes (8 papers)Esophageal Cancer Research and Treatment (3 papers)
- Partner nations
- SwitzerlandSouth KoreaChina
In The Last Decade
Julie Hill
14 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Pulmonary and Respiratory Medicine 3.8k
- Oncology 3.5k
- Surgery 1.7k
- Molecular Biology 1.2k
- Gastroenterology 1.2k
Countries citing papers authored by Julie Hill
This map shows the geographic impact of Julie Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Hill more than expected).
Fields of papers citing papers by Julie Hill
This network shows the impact of papers produced by Julie Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Hill. The network helps show where Julie Hill may publish in the future.
Co-authorship network of co-authors of Julie Hill
This figure shows the co-authorship network connecting the top 25 collaborators of Julie Hill. A scholar is included among the top collaborators of Julie Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Hill. Julie Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 9 | |
| 3 | 36 | |
| 4 | HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancerbreakdown → | 426 |
| 5 | 2 | |
| 6 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialbreakdown → | 5261 |
| 7 | 69 | |
| 8 | 24 | |
| 9 | 148 | |
| 10 | 3 | |
| 11 | 2 | |
| 12 | 52 | |
| 13 | Combination chemotherapy of leukemia l1210 with platinum compounds and vitamins. | 2 |
| 14 | Treatment of leukemia, lymphoma, and other malignant neoplasms with Vinblastine. | 14 |
About Julie Hill
Julie Hill is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 6.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Gastric Cancer Management and Outcomes (8 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Gastroenterology (1.2k citations), Oncology (3.5k citations) and Pulmonary and Respiratory Medicine (3.8k citations). Julie Hill has collaborated with scholars based in Switzerland, South Korea and China. Frequent co-authors include Eric Van Cutsem, Michaela Lehle, Yung‐Jue Bang, A. Feyereislova, Florian Lordick, Yoon‐Koo Kang, Akira Sawaki, Josef Rüschoff, Hyun Cheol Chung and Atsushi Ohtsu. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.